First Time Loading...
I

Immune Pharmaceuticals Inc
OTC:IMNPQ

Watchlist Manager
Immune Pharmaceuticals Inc
OTC:IMNPQ
Watchlist
Price: 0.001 USD Market Closed
Updated: May 3, 2024

Immune Pharmaceuticals Inc
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Immune Pharmaceuticals Inc
Cash from Operating Activities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
I
Immune Pharmaceuticals Inc
OTC:IMNPQ
Cash from Operating Activities
-$11.6m
CAGR 3-Years
6%
CAGR 5-Years
-33%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Cash from Operating Activities
$22.8B
CAGR 3-Years
9%
CAGR 5-Years
11%
CAGR 10-Years
14%
Gilead Sciences Inc
NASDAQ:GILD
Cash from Operating Activities
$8B
CAGR 3-Years
-5%
CAGR 5-Years
1%
CAGR 10-Years
7%
Amgen Inc
NASDAQ:AMGN
Cash from Operating Activities
$8.5B
CAGR 3-Years
-7%
CAGR 5-Years
-6%
CAGR 10-Years
3%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Cash from Operating Activities
$3.5B
CAGR 3-Years
3%
CAGR 5-Years
23%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Cash from Operating Activities
$4.6B
CAGR 3-Years
21%
CAGR 5-Years
16%
CAGR 10-Years
23%

See Also

What is Immune Pharmaceuticals Inc's Cash from Operating Activities?
Cash from Operating Activities
-11.6m USD

Based on the financial report for Dec 31, 2017, Immune Pharmaceuticals Inc's Cash from Operating Activities amounts to -11.6m USD.

What is Immune Pharmaceuticals Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
-33%

Over the last year, the Cash from Operating Activities growth was 6%. The average annual Cash from Operating Activities growth rates for Immune Pharmaceuticals Inc have been 6% over the past three years , -33% over the past five years .